US FDA will be cautious about development of a COVID-19 vaccine for children, Commissioner Hahn says at the Financial Times US Pharma And Biotech Summit.

The US FDA appears to have concerns about the device used to administer the vaccine.

Revlimid, Copaxone, Sensipar, Enbrel, Acthar Gel and Gleevec will be the subject of a US House Committee on Oversight and Reform in an upcoming drug price hearing.

Pfizer was heavily invested in immuno-oncology combinations five years ago, but following setbacks, the pipeline has shifted considerably, shaped partly by the acquisition of Array.

The company is planning a direct-to-consumer education campaign to inform the public about the importance of vaccination.

The company showcased its pipeline in a two-day virtual meeting, trying to convince investors the long-term potential is undervalued.